Investment
Features
FeesSafety
Academy
More
Pluang+

Tilray's strong Q3 cannabis sales and positive outlook boost shares 8% with Jefferies maintaining Buy rating.

Analyst Insights
02 Apr 2026
Proactive Investors
View Source
Bullish
pluang ai news

Tilray Inc reported an 11.3% revenue growth in Q3, driven by a 19% rise in cannabis sales despite a 24% drop in craft beer. Jefferies analysts reaffirmed a Buy rating with a $24 price target, citing improving fundamentals and strong international cannabis growth of 73%. The company expects full-year revenue of about $1.1 billion and adjusted EBITDA of $95 million for fiscal 2026, supported by strategic partnerships and supply chain improvements. Jefferies remains optimistic about Tilray's future growth, especially from international markets and potential U.S. regulatory changes.

More News (TLRY)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App